Goodbody Health Share Price Canadian Securities Exchange
Equities
SWEL
CA3821591011
Pharmaceuticals
Sales 2020 | 1.99M 2.49M 3.41M 199M | Sales 2021 | 17.06M 21.31M 29.13M 1.71B | Capitalization | 13.76M 17.19M 23.49M 1.38B |
---|---|---|---|---|---|
Net income 2020 | -4M -5M -6.83M -400M | Net income 2021 | -2M -2.5M -3.42M -200M | EV / Sales 2020 | 5.41 x |
Net cash position 2020 | 1.37M 1.72M 2.34M 137M | Net cash position 2021 | 5.73M 7.16M 9.79M 573M | EV / Sales 2021 | 0.47 x |
P/E ratio 2020 |
-1.4
x | P/E ratio 2021 |
-5.64
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 70.26% |
Managers | Title | Age | Since |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 25/01/21 |
Geremy Thomas
FOU | Founder | 64 | 13/02/11 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 13/02/11 |
George Thomas
CEO | Chief Executive Officer | 35 | 25/01/21 |
Anne Tew
SEC | Corporate Secretary | - | 31/10/18 |
1st Jan change | Capi. | |
---|---|---|
+35.04% | 5.92B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B |